An original accelerated radiotherapy schedule in stage III to IV head and neck cancers. Results in a multicenter setting

Strahlentherapie und Onkologie

Volumn 176, Issue 1, 2000, Pages 28-31

  Allal, Abdelkarim S ^a   Monney, May ^b   Rosset, Anna ^b   Ozsahin, Mahmut ^b   Guillemin, Clare ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b NONE

Author keywords

Accelerated radiotherapy; Chemotherapy; Head and neck cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RADIATION DOSE FRACTIONATION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0033985657     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00002301     Document Type: Article

References (20)

1. Allal AS, Bieri S, Miralbell R, et al. Feasibility and outcome of a progressively accelerated concomitant boost radiotherapy schedule for head and neck carcinomas. Int J Radiat Oncol Biol Phys 1997;38:685-9.
2. Allal AS, Miralbell R, Pipard G, et al. Early and long-term results of an original accelerated radiation therapy schedule in head and neck carcinoma. Acta Oncol 1997;36:267-71.
3. Dische S, Saunders M, et al. A randomized multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997;44:123-36.
4. El-Sayed S, Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: a meta-analysis of prospective and randomized trials. J Clin Oncol 1996;14: 838-47.
5. Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992;23:457-67.
6. Fu KK, Clery MBS, Ang KK, et al. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09. Int J Radiat Oncol Biol Phys 1995;32:589-97.
7. Horiot JC, Bontemps P, Van den Bogaert W, et al. Accelerated fractionation compared to conventional fractionation improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 1997; 44: 111-21.
8. Horiot JC, Le Fur R, N'Guyen T, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992;25:231-41.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
10. Knee R, Fields RS, Peters LJ. Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1985;4:1-7.
11. Merlano M, Vitale V, Rosso R, et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 1992;327:1115-21.
12. Miralbell R, Allal AS, Mermillod B, et al. The influence of field size and other radiotherapy parameters on acute toxicity in pharyngolaryngeal cancers. Strahlenther Onkol 1999;175:74-7.
13. Mucke R, Blynow M, Ziegler PG, et al. [Simultaneous radiochemotherapy with carboplatin in patients with inoperable advanced stage III and IV head and neck tumors]. Strahlenther Onkol 1999;175:213-7.
14. Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995;71:83-91.
15. Overgaard J, Hansen HS, Sapru W, et al. Conventional radiotherapy as the primary treatment of squamous cell carcinoma of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week - preliminary report from the DAHANCA 6 and 7 trial. Radiother Oncol 1996;40:Suppl 1:S31.
16. Peracchia G, Salti C. Radiotherapy with thrice-a-day fractionation in a short overall time. Clinical experience. Int J Radiat Oncol Biol Phys 1981;7:99-104.
17. Perez CA, Brady LW. Overview. In: Perez CA, Brady LW, eds. Principles and practice of radiation oncology. Philadelphia: Lippincott 1992:51.
18. Van den Bogaert W, Van der Schueren E, Horiot JC, et al. Early results of the EORTC randomized clinical trial on multiple fractions per day (MFD) and misonidazole in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1986;12:587-91.
19. Wang CC, Blitzer PH, Suit H. Twice-a-day radiation therapy for cancer of the head and neck. Cancer 1985;55:2100-4.
20. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988;27: 131-46.